在结核病治疗中,长期的门诊亲肠道抗菌药物疗法是自给自取的
A Rauch1,2,3, N Köhler4,5,6,7, T T Brehm1,2,8
1Division of Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
Drugs
|December 29, 2024
概括
自治室门诊关节肠道抗菌疗法 (sOPAT) 是对精选的结核病患者,包括具有耐药菌株的患者,可行的治疗方法. 这种方法表明,当提供适当的基础设施和培训时,并发症风险较低.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 抗微生物药物管理委员会
背景情况:
- 结核病 (TB) 的治疗通常需要长期的静脉注射抗菌药物治疗.
- 耐药结核病菌株需要复杂和延长的治疗方案.
- 门诊亲肠道抗微生物疗法 (OPAT) 为长时间住院提供了替代方案.
研究的目的:
- 在一组结核病患者中,评估自我管理的门诊亲肠道抗菌药物治疗 (sOPAT) 的安全性和临床结果.
- 评估sOPAT对患有多抗药性 (MDR) 结核病和前广泛耐药性 (XDR) 结核病的患者的可行性.
- 在结核病治疗的背景下,识别与sOPAT相关的并发症.
主要方法:
- 在德国临床推中心进行的回顾性观察队列研究.
- 包括2015年1月至2020年12月期间接受sOPAT的患者.
- 从医疗记录中提取数据,用于安全性和结果分析.
主要成果:
- 89名结核病患者,主要是MDR-TB或XDR-TB前期,接受了sOPAT.
- 大多数患者 (69.7%) 成功完成了他们的sOPAT治疗方案.
- 停止治疗的常见原因包括不良药物事件 (13.5%),与港口相关的并发症发生在9.0%的患者.
结论:
- 对于需要长期静脉注射治疗的精选结核病患者来说,sOPAT是一种可行且安全的治疗选择.
- 成功实施sOPAT取决于适当的基础设施和患者培训.
- 这种方法可以减少结核病患者长期住院的负担.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
Pulmonary Tuberculosis III
303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
303


